Patients who are carriers of a thrombophilic gene variant (e.g., factor V A1691G and∖or prothrombin A20210G) or other thrombotic risk factors are susceptible to the inherited or acquired thrombophilia. This evidence concerns the gene F2 and Rare hereditary thrombophilia.